BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 35121990)

  • 1. ENO1 suppresses cancer cell ferroptosis by degrading the mRNA of iron regulatory protein 1.
    Zhang T; Sun L; Hao Y; Suo C; Shen S; Wei H; Ma W; Zhang P; Wang T; Gu X; Li ST; Chen Z; Yan R; Zhang Y; Cai Y; Zhou R; Jia W; Huang F; Gao P; Zhang H
    Nat Cancer; 2022 Jan; 3(1):75-89. PubMed ID: 35121990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targetting an LncRNA P5848-ENO1 axis inhibits tumor growth in hepatocellular carcinoma.
    Zhu X; Yu H; Li B; Quan J; Zeng Z; Li G; Liu J
    Biosci Rep; 2019 Nov; 39(11):. PubMed ID: 30541900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel lncRNA, TCONS_00006195, represses hepatocellular carcinoma progression by inhibiting enzymatic activity of ENO1.
    Yu S; Li N; Huang Z; Chen R; Yi P; Kang R; Tang D; Hu X; Fan X
    Cell Death Dis; 2018 Dec; 9(12):1184. PubMed ID: 30518748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ENO1 promotes liver carcinogenesis through YAP1-dependent arachidonic acid metabolism.
    Sun L; Suo C; Zhang T; Shen S; Gu X; Qiu S; Zhang P; Wei H; Ma W; Yan R; Chen R; Jia W; Cao J; Zhang H; Gao P
    Nat Chem Biol; 2023 Dec; 19(12):1492-1503. PubMed ID: 37500770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Role of enolase 1 in hepatocellular carcinoma and possible mechanism].
    Yan TT; Ma LN; Luo X; Lu ZH; Liu Q; Xu YH; Liu XL; Ding XC
    Zhonghua Gan Zang Bing Za Zhi; 2017 Jun; 25(6):429-434. PubMed ID: 28763860
    [No Abstract]   [Full Text] [Related]  

  • 6. Exosome-derived ENO1 regulates integrin α6β4 expression and promotes hepatocellular carcinoma growth and metastasis.
    Jiang K; Dong C; Yin Z; Li R; Mao J; Wang C; Zhang J; Gao Z; Liang R; Wang Q; Wang L
    Cell Death Dis; 2020 Nov; 11(11):972. PubMed ID: 33184263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iron regulatory protein-1 protects against mitoferrin-1-deficient porphyria.
    Chung J; Anderson SA; Gwynn B; Deck KM; Chen MJ; Langer NB; Shaw GC; Huston NC; Boyer LF; Datta S; Paradkar PN; Li L; Wei Z; Lambert AJ; Sahr K; Wittig JG; Chen W; Lu W; Galy B; Schlaeger TM; Hentze MW; Ward DM; Kaplan J; Eisenstein RS; Peters LL; Paw BH
    J Biol Chem; 2014 Mar; 289(11):7835-43. PubMed ID: 24509859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enolase1 overexpression regulates the growth of gastric cancer cells and predicts poor survival.
    Qiao H; Wang Y; Zhu B; Jiang L; Yuan W; Zhou Y; Guan Q
    J Cell Biochem; 2019 Nov; 120(11):18714-18723. PubMed ID: 31218757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enolase 1 stimulates glycolysis to promote chemoresistance in gastric cancer.
    Qian X; Xu W; Xu J; Shi Q; Li J; Weng Y; Jiang Z; Feng L; Wang X; Zhou J; Jin H
    Oncotarget; 2017 Jul; 8(29):47691-47708. PubMed ID: 28548950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A preliminary study of serum marker alpha-enolase in the diagnosis of hepatocellular carcinoma].
    Luo X; Wei YQ; Hai L; Hu YC; Zhao ZJ; Ma WL; Ma LN; Liu XY; Ding XC
    Zhonghua Gan Zang Bing Za Zhi; 2019 Jul; 27(7):505-510. PubMed ID: 31357775
    [No Abstract]   [Full Text] [Related]  

  • 11. Interaction between granulin A and enolase 1 attenuates the migration and invasion of human hepatoma cells.
    Chen X; Xu H; Wu N; Liu X; Qiao G; Su S; Tian Y; Yuan R; Li C; Liu X; Lin X
    Oncotarget; 2017 May; 8(18):30305-30316. PubMed ID: 28415822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha-enolase is a potential prognostic marker in clear cell renal cell carcinoma.
    White-Al Habeeb NM; Di Meo A; Scorilas A; Rotondo F; Masui O; Seivwright A; Gabril M; Girgis AH; Jewett MA; Yousef GM
    Clin Exp Metastasis; 2015 Aug; 32(6):531-41. PubMed ID: 26037892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The immunoregulatory role of alpha enolase in dendritic cell function during Chlamydia infection.
    Ryans K; Omosun Y; McKeithen DN; Simoneaux T; Mills CC; Bowen N; Eko FO; Black CM; Igietseme JU; He Q
    BMC Immunol; 2017 May; 18(1):27. PubMed ID: 28525970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of Alpha-Enolase (ENO1), Myc Promoter-Binding Protein-1 (MBP-1) and Matrix Metalloproteinases (MMP-2 and MMP-9) Reflect the Nature and Aggressiveness of Breast Tumors.
    Cancemi P; Buttacavoli M; Roz E; Feo S
    Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31416219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enolase-1 is a therapeutic target in endometrial carcinoma.
    Zhao M; Fang W; Wang Y; Guo S; Shu L; Wang L; Chen Y; Fu Q; Liu Y; Hua S; Fan Y; Liu Y; Deng X; Luo R; Mei Z; Jiang Q; Liu Z
    Oncotarget; 2015 Jun; 6(17):15610-27. PubMed ID: 25951350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. α-enolase promotes tumorigenesis and metastasis via regulating AMPK/mTOR pathway in colorectal cancer.
    Zhan P; Zhao S; Yan H; Yin C; Xiao Y; Wang Y; Ni R; Chen W; Wei G; Zhang P
    Mol Carcinog; 2017 May; 56(5):1427-1437. PubMed ID: 27996156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of α enolase (ENO1) crotonylation in colorectal cancer and its promoting effect on cancer cell metastasis.
    Hou JY; Cao J; Gao LJ; Zhang FP; Shen J; Zhou L; Shi JY; Feng YL; Yan Z; Wang DP; Cao JM
    Biochem Biophys Res Commun; 2021 Nov; 578():77-83. PubMed ID: 34547627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha-enolase in viral target cells suppresses the human immunodeficiency virus type 1 integration.
    Kishimoto N; Yamamoto K; Iga N; Kirihara C; Abe T; Takamune N; Misumi S
    Retrovirology; 2020 Sep; 17(1):31. PubMed ID: 32917235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Up-regulated ENO1 promotes the bladder cancer cell growth and proliferation via regulating β-catenin.
    Ji M; Wang Z; Chen J; Gu L; Chen M; Ding Y; Liu T
    Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31431517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting of surface alpha-enolase inhibits the invasiveness of pancreatic cancer cells.
    Principe M; Ceruti P; Shih NY; Chattaragada MS; Rolla S; Conti L; Bestagno M; Zentilin L; Yang SH; Migliorini P; Cappello P; Burrone O; Novelli F
    Oncotarget; 2015 May; 6(13):11098-113. PubMed ID: 25860938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.